AlloSource receives patent for bone allograft: 3 points

Spinal Tech

AlloSource has received a patent for its regenerative medicine product AlloStem Cellular Bone Allograft.

Here are three points:

 

1. The patent is titled "allografts combined with tissue derived stem cells for bone healing."

 

2. The patent is related to AlloStem's partially demineralized allograft bone combined with adipose derived mesenchymal stem cells.

 

3. AlloSource is one of the largest nonprofit cellular and tissue networks in the country.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers